Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's—tau protein and beta-amyloid ...

As of 2019, nearly one in two Americans over age 55 are at risk of dementia, according to the Census Bureau’s report.

Prehospital hypoxia, hypotension, and hypocarbia each were associated with poor outcomes after traumatic brain injury, ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

Whether you're curious to explore a healthy brain or brains affected by Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, or Frontotemporal dementia, the choice is yours. Tailoring ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.

Advocates for people diagnosed with Alzheimer’s disease and dementia say the AHCCCS screening process is causing long delays in getting patients the care they need.

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...